These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

93 related items for PubMed ID: 14136521

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Densitometric determination of impurities in pharmaceuticals. Part VI. Determination of 4,4-bis[4-(p-chlorophenyl)- 4-hydroxypiperidino]butyrophenone in haloperidol.
    Krzek J, Maślanka A.
    Acta Pol Pharm; 2000; 57(1):23-6. PubMed ID: 10846793
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [THE USE OF A BUTYROPHENONE NEUROLEPTIC (HALOPERIDOL) IN ACUTE AND CHRONIC PSYCHOSES].
    MADALENA JC, FERREIRA LR, BELLO H.
    Rev Assoc Med Bras; 1963; 9():375-86. PubMed ID: 14163287
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Study of the therapeutic effects of a butyrophenone (R-1625--Haloperidin--haloperidol) in psychoses].
    PALAIOLOGOS A, SIGALOS I, SPATHARAS G, TERENTIOS E.
    Hell Iatr; 1963 May; 32():473-502. PubMed ID: 13941173
    [No Abstract] [Full Text] [Related]

  • 11. Randomized double-blind study with prednisone in Sydenham's chorea.
    Paz JA, Silva CA, Marques-Dias MJ.
    Pediatr Neurol; 2006 Apr; 34(4):264-9. PubMed ID: 16638499
    [Abstract] [Full Text] [Related]

  • 12. [EFFECTS OF CORTICOTHERAPY ON THE SCHOLASTIC BEHAVIOR OF THE CHILD].
    AUDIER M, SALVINI A, MAGARDITCHIAN A.
    Pediatrie; 1964 Jun; 19():499-501. PubMed ID: 14162622
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. The therapeutic profile of haloperidol. A preliminary study of a butyrophenone derivative in in-patients and out-patients.
    PALEY HM, HANKOFF LD, KAWI AA, MENDELSOHN FS.
    J Neuropsychiatr; 1962 Jun; 4():39-42. PubMed ID: 13941197
    [No Abstract] [Full Text] [Related]

  • 16. [Results of psychiatric therapy with the butyrophenone derivative haloperidol (R1625)].
    GEYER N, MAYR F.
    Wien Med Wochenschr; 1962 Aug 04; 112():603-7. PubMed ID: 13898165
    [No Abstract] [Full Text] [Related]

  • 17. [Psycho-pharmacological study of a 5th butyrophenone: "methylperidide", a neuroleptic pyrrolidinamide and methyl derivative of haloperidol].
    DIVRY P, BOBON J, COLLARD J, DEMARET A.
    Acta Neurol Psychiatr Belg; 1960 Dec 04; 60():1073-86. PubMed ID: 13723131
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.